Woo-Jin Shin

Senior Scientist II, Virology

Greater Chicago Area

About

An experienced researcher in the field of virology, antivirals, and vaccines with a strong chemistry, biochemistry, and engineering background. - Skilled in protein purification and expression, cell culture, virus propagation and titration, viral reverse genetics, and animal handling. - Experienced project lead for research programs of high unmet medical need. - Authored or coauthored in multiple peer-reviewed journals in the field of virology. - Eager to identify novel viral/host targets for the development of antivirals and vaccines. A full publication list can be found on Google Scholar: https://scholar.google.com/citations?hl=en&user=gPQywLEAAAAJ&view_op=list_works&sortby=pubdate

Experience

  • Senior Scientist II Virology at AbbVie
    Dec 2025 - Present · 8 mos

  • Scientist II Virology at XBiotech USA, Inc.
    Jun 2025 - Dec 2025 · 7 mos

  • Research Associate at Cleveland Clinic Lerner Research Institute
    Sep 2023 - Jun 2025 · 1 yr 10 mos

    - Investigate the mechanism of how the cis-acting factors contribute to bunyavirus reassortment - Identification and characterization of novel host factor involved in SARS-CoV-2 viral protein post-translational modification - Generation of GFP-tagged Powassan virus as a tool for anti-Powassan virus drug discovery - Optimization of non-covalent inhibitors targeting the SARS-CoV-2 3CL protease

  • Research Associate at Cleveland Clinic Florida Research and Innovation Center
    Aug 2020 - Dec 2023 · 3 yrs 5 mos

    - Viral replication mechanism-based rational design of influenza live vaccine - Characterize GRP78 as a proviral host factor for SARS-CoV-2 replication - Evaluate the antiviral activity of GRP78 inhibitors against SARS-CoV-2 - Generation of GFP-tagged Powassan virus as a tool for anti-Powassan virus drug discovery - Optimization of non-covalent inhibitors targeting the SARS-CoV-2 3CL protease

  • University of Southern California ()
    • Research Associate
      Feb 2018 - Jul 2020 · 2 yrs 6 mos

      - Characterize GRP78 as a proviral host factor for SARS-CoV-2 replication - Evaluate the virucidal activity of light-activated TiO2 against SARS-CoV-2 - Characterize viral endonuclease domain of Dabie bandavirus - Identification of cap-binding domain of Dabie bandavirus

    • Postdoctoral Research Associate
      Feb 2016 - Feb 2018 · 2 yrs 1 mo

      - Development of thermal stable polio vaccine - Characterize viral endonuclease domain of Dabie bandavirus - Identification of cap-binding domain of Dabie bandavirus